Tag Archives: Human herpesvirus 6

Cytomegalovirus, Epstein‐Barr virus, & human herpesvirus‐6 infections in patients with ME/CFS (Bulgaria)

Posted on 03/11/2020 by wames

Cytomegalovirus, Epstein‐Barr Virus and Human Herpesvirus 6 infections in patients with Myalgic Еncephalomyelitis/Chronic Fatigue Syndrome, by Evelina Shikova, Valentina Reshkova, Аntoniya Kumanova, Sevdalina Raleva,Dora Alexandrova, Natasa Capo, Modra Murovska ( on behalf of the European Network on ME/CFS (EUROMENE) in … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on Cytomegalovirus, Epstein‐Barr virus, & human herpesvirus‐6 infections in patients with ME/CFS (Bulgaria)

Human herpesvirus 6 and the nervous system

Posted on 07/31/2014 by wames

Human herpesvirus (HHV)-6 is a β-herpesvirus that infects most infants by 2 years of age and persists in a variety of host cells after primary infection, with intermittent reactivation typically during periods of immunosuppression. HHV-6 has two closely related species, … Continue reading →

Posted in News | Tagged , , , | Comments Off on Human herpesvirus 6 and the nervous system

Valganciclovir is potential treatment for CFS subset

Posted on 09/02/2013 by wames

Research abstract  There is no known treatment for chronic fatigue syndrome (CFS). Little is known about its pathogenesis. Human herpesvirus 6 (HHV-6) and Epstein–Barr virus (EBV) have been proposed as infectious triggers. Method: Thirty CFS patients with elevated IgG antibody … Continue reading →

Posted in News | Tagged , , , | Comments Off on Valganciclovir is potential treatment for CFS subset

Antiviral valganciclovir helps CFS subgroup

Posted on 10/18/2012 by wames

In a study by Dr Jose Montoya in the USA half of CFS patients suffering from HHV-6 and EBV viruses make an improvement of 30% or more. Abstract Valganciclovir has been reported to improve physical and cognitive symptoms in patients … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on Antiviral valganciclovir helps CFS subgroup